Company page

Hem Pharma, Inc.

Hem Pharma, Inc. is a public company traded under the ticker 376270 on the Korean market. The company has a market capitalization of approximately 234.66 million. Hem Pharma focuses on developing innovative pharmaceutical solutions to meet healthcare needs.

profile376270:KRXAI content: aiUpdated June 24, 2026/company/hem-pharma-inc/c-awsbsdar
Hem Pharma, Inc. logo
Ticker
376270:KRX
Asset type
Stock
Market cap
$234.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
KRX
Currency
KRW